1.94
0.00%
0.00
After Hours:
1.93
-0.01
-0.52%
Virax Biolabs Group Ltd stock is traded at $1.94, with a volume of 237.62K.
It is up +0.00% in the last 24 hours and down -58.37% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
See More
Previous Close:
$1.94
Open:
$1.92
24h Volume:
237.62K
Relative Volume:
0.05
Market Cap:
$8.42M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-3.0398
EPS:
-0.6382
Net Cash Flow:
$-5.34M
1W Performance:
-13.00%
1M Performance:
-58.37%
6M Performance:
+170.57%
1Y Performance:
+496.92%
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Virax Biolabs Plans New Share Offering - TipRanks
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World
Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle
How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News
Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex
Virax Biolabs Group Ltd (VRAX)’s Day in Review: Closing at 2.84, Up by 9.65 - The Dwinnex
Virax Biolabs Group Ltd Inc. (VRAX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
A closer look at VRAX’s price-to-free cash flow ratio - US Post News
Cosmos Health expands mpox kit distribution to Gulf States - Investing.com India
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Lelezard
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Yahoo Finance
Ratios Reveal: Breaking Down Virax Biolabs Group Ltd (VRAX)’s Financial Health - The Dwinnex
VRAX’s 2023 Market Dance: Up 140.41% – Time to Invest? - The InvestChronicle
Investing in Virax Biolabs Group Ltd (VRAX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Closing Figures Unveiled: Virax Biolabs Group Ltd (VRAX) Drop -12.90, Closes at 3.51 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) requires closer examination - US Post News
Post-Trade Analysis: Virax Biolabs Group Ltd (VRAX) Slides -7.91, Closing at 4.66 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Luminar Technologies Inc (NASDAQ: LAZR) Shares Look Bullish In 2024 - Stocks Register
NuCana halts NuTide:323 study on colorectal cancer - Investing.com
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com Australia
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com UK
Virax Biolabs to Participate at 7th European Congress of Immunology - Quantisnow
Wall Street-Heavily Traded - WDRB
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - LongPort
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN
Russia bans entry to dozens of American journalists, including WSJ, NYT and Washington Post - CNN International
Virax stock soars on Mpox tests deal in Europe and Middle East - Invezz
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - TradingView
Virax Biolabs expands Mpox test kit distribution in Europe, GCC By Investing.com - Investing.com Australia
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - Yahoo Finance
Virax Biolabs signs distribution agreement for Mpox virus detection kits - TipRanks
Virax Biolabs Group Ltd (VRAX) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Closing Figures: Virax Biolabs Group Ltd (VRAX)’s Negative Finish at 4.61, Down -15.41 - The Dwinnex
There is no way Virax Biolabs Group Ltd (VRAX) can keep these numbers up - SETE News
Monkeypox Stocks Round 2: Mpox Stocks - Wealth Daily
Virax Biolabs Introduces New Share Purchase Warrant - TipRanks
Pre-market Movers: SQNS, MNTS, UBXG, PRTG, PTWO… - RTTNews
Canadian government forces rail lockout to end - CNN International
Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results - Quantisnow
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Fake celebrity endorsements become latest weapon in misinformation wars, sowing confusion ahead of 2024 election - CNN International
Canadian freight railroads shut down, dealing a potential blow to North America’s economy - CNN International
Cosmos Health secures distribution rights for mpox PCR kits - Investing.com India
Judge blocks Arizona lithium drilling that tribe says is threat to sacred lands - 69News WFMZ-TV
Nu Asset FICFII Em Debentures De Infraestrutura Renda Fixa Credito Privado (NUIF11.SA) - Yahoo Finance
Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares - Yahoo Finance
New data shows US job growth has been far weaker than initially reported - CNN International
Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits - Yahoo Finance
Trading Day Review: Virax Biolabs Group Ltd (VRAX) Loses Momentum, Closing at 3.56 - The Dwinnex
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):